Dott. Pietro GALLOTTI

Specializzazione in Reumatologia - Università degli Studi di Pavia

Specializzazione in Oncologia - Università degli Studi di Genova

Specializzazione in Medicina Interna - Università degli Studi di Pavia

Laurea in Medicina e Chirurgia - Università degli Studi di Pavia

• 1.Montalcini T et al., 2015, Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes, Osteoporos Int., Epub ahead of print - Tesi

• 3.Gazzaruso C et al., 2013, Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index, Diabetes Care - Tesi

• 2.Gazzaruso C et al., 2013, Percutaneous transluminal angioplasty for critical limb ischemia in very elderly diabetic patients, Aging Clin Exp Res - Tesi

• 6.Gazzaruso C. et al., 2012, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus, Endocrine, Springer, 41: 89-95 - Articolo

• 5.Gazzaruso C. et al., 2012, Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients, Internal and Emergency Medicine, Springer, 7: 257-266 - Articolo

• 4.Gazzaruso C et al., 2012, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus, Endocrine - Tesi

• 7.Gazzaruso C. et al., 2011, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes, Endocrine, Springer, 40: 273-279 - Articolo

• 8.Conte P. F. et al., 1996, Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO), Annals of Oncology, Kluver Academic Publishers, 7: 487-490 - Articolo

• 9.Veronesi U. et al., 1995, Prevention of breast cancer with tamoxifen: the Italian study in hysterectomized women, The Breast, Pearson Professional, 4: 267-272 - Articolo

• 11.Canobbio L. et al., 1992, Treatment of Advanced Pancreatic Carcinoma with the Somatostin Analogue BIM 23014, Cancer, American Cancer Society, Inc. J.B. Lippincott Company, 69: 648-650 - Articolo

• 10.Nobile M. T. et al., 1992, Randomised Comparison of Weekly Bolus 5-fluoruoracil with or without Leucovorin in Metastatic Colorectal Carcinoma, Eur F Cancer, Pergamon Press, 28A: 1823-1827 - Articolo

• 12.Conte P. F. et al., 1990, In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results, J. Steroid Biochem. Molec. Biol., Pergamon Press plc, 37: 1103-1108 - Articolo

• 14.Brema F. et al., 1988, Phase II study with Tamoxifen (TMX) and high-dose Retinyl Acetate (RA) in metastatic breast cancer patients (PTS), Advances in Management of Malignancies, Monduzzi Editore, 381-385 - Articolo

• 13.Sertoli M. R. et al., 1988, A randomized trial of combined versus sequential chemo-hormotherapy (CHT) as adjuvant treatment of stage II breast cancer (BC), International symposium on endocrine therapy, Atti del Congresso, 80 - Articolo

• 16.Gulisano M. et al., 1987, Polichemioterapia alternante con ciclofosfamide/adriamicina/vincristina (CAV) e platino/etoposide (PE) nel trattamento del microcitoma polmonare, Annali dell'Istituto Carlo Forlanini, Edizioni Luigi Pozzi, VII: 339 - Articolo